Global Stem Cell Therapy Market By Type (Allogeneic, Autologous, Syngeneic), By Source of Stem Cells (Adipose Tissue, Bone Marrow, Neural, Embryo/Cord Blood derived, iPSCs, Others), By Application, By End Users, By Region, Forecast & Opportunities, 2025

The Global Stem Cell Therapy Market is expected to grow at a formidable rate of around 12% during the forecast period. The Global Stem Cell Therapy Market is driven by the growing popularity and awareness pertaining to the use of stem cells for the prevention and cure of certain life threatening diseases. Additionally, increase in number of stem cell banks and growing investments by the government and private organizations for the development of stem cell preservation infrastructure is further propelling the market across the globe.

The Global Stem Cell Therapy Market is segmented based on type, source of stem cells, application, end-users, company and region. Based on type, the market can be categorized into allogeneic, autologous and syngeneic. The allogenic type segment is expected to register the highest growth during forecast period attributable to the rising commercialization of allogeneic stem cell therapy products, wider therapeutic applications of allogeneic stem cells, easy production scale-up process, growing number of clinical trials related to allogeneic stem cell therapies, among others. Based on end-users, the market can be bifurcated into hospitals and clinics. The hospitals segment is expected to dominate the market during the forecast years. This can be accredited to the rising preference for stem cell therapies offered by hospitals proves beneficial for the business growth. Hospitals have affiliations with research laboratories and academic institutes that carry out research activities for developing stem cell therapies. On introduction and approval of any novel stem therapy, hospitals implement it immediately.

Regionally, the stem cell therapy market has been segmented into various regions namely Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, North America is expected to dominate the overall stem cell therapy market during the next five years on account of the increasing number of clinical trials for stem cell-based products and increasing public-private funding & research grants.

Major players operating in the Global Stem Cell Therapy Market include Osiris Therapeutics, Inc., MEDIPOST Co., Ltd., Anterogen Co., Ltd., Pharmicell Co., Ltd., Holostem Terapie Avanzate S.r.l., JCR Pharmaceuticals Co., Ltd., NuVasive, Inc., RTI Surgical, Inc., AlloSource, Thermo Fisher Scientific and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market.

Years considered for this report:

Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025

Objective of the Study:

To analyze and forecast the market size of the Global Stem Cell Therapy Market.
To classify and forecast the Global Stem Cell Therapy Market based on type, source of stem cells, application, end-users, company and regional distribution.
To identify drivers and challenges for the Global Stem Cell Therapy Market.
To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Stem Cell Therapy Market.
To identify and analyze the profile of leading players operating in the Global Stem Cell Therapy Market.

The author performed both primary as well as exhaustive secondary research for this study. Initially, researchers sourced a list of hospitals/clinics across the globe. Subsequently, they conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, researchers could include the hospitals/clinics which could not be identified due to the limitations of secondary research. The author analyzed the hospitals/clinics, end-users, channels and presence of all major players across the globe.

The author calculated the market size of the Global Stem Cell Therapy Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. Researchers sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:

Stem Cell therapy hospitals, clinics and other stakeholders
Government bodies such as regulating authorities and policy makers
Organizations, forums and alliances related to stem cell therapy
Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals, clinics and partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:
In this report, the Global Stem Cell Therapy Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Type:

Allogeneic
Autologous
Syngeneic

Market, By Source of Stem Cells:

Adipose Tissue
Bone Marrow
Neural
Embryo/Cord Blood Derived
iPSCs
Others

Market, By Application:

Musculoskeletal
Wound & Injury
Cardiovascular Disease (CVD)
Surgery
Acute Graft-Versus-Host Disease
Drug Discovery & Development
Others

Market, By End-Users:

Hospitals
Clinics

Market, By Region:

North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Asia-Pacific
China
Japan
India
South Korea
Australia
Middle East & Africa
South Africa
Saudi Arabia
UAE
South America
Brazil
Argentina
Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Stem Cell Therapy Market.

Available Customizations:
With the given market data, the author offers customizations according to a client's specific needs.

1. Product Overview2. Research Methodology3. Executive Summary4. Voice of Customer

5. Global Stem Cell Therapy Market Outlook

5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Allogeneic, Autologous, Syngeneic)
5.2.2. By Source of Stem Cells (Adipose Tissue, Bone Marrow, Neural, Embryo/Cord Blood Derived, iPSCs, Others)
5.2.3. By Application (Musculoskeletal, Wound & Injury, Cardiovascular Disease (CVD), Surgery, Acute Graft-Versus-Host Disease, Drug Discovery & Development, Others)
5.2.4. By End Users (Hospitals v/s Clinics)
5.2.5. By Company (2019)
5.2.6. By Region
5.3. Product Market Map

6. Asia-Pacific Stem Cell Therapy Market Outlook

6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Source of Stem Cells
6.2.3. By Application
6.2.4. By End Users
6.2.5. By Country
6.3. Asia-Pacific: Country Analysis
6.3.1. China Stem Cell Therapy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Source of Stem Cells
6.3.1.2.3. By Application
6.3.1.2.4. By End Users
6.3.2. India Stem Cell Therapy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Source of Stem Cells
6.3.2.2.3. By Application
6.3.2.2.4. By End Users
6.3.3. Australia Stem Cell Therapy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Source of Stem Cells
6.3.3.2.3. By Application
6.3.3.2.4. By End Users
6.3.4. Japan Stem Cell Therapy Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Type
6.3.4.2.2. By Source of Stem Cells
6.3.4.2.3. By Application
6.3.4.2.4. By End Users
6.3.5. South Korea Stem Cell Therapy Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Type
6.3.5.2.2. By Source of Stem Cells
6.3.5.2.3. By Application
6.3.5.2.4. By End Users

7. Europe Stem Cell Therapy Market Outlook

7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Source of Stem Cells
7.2.3. By Application
7.2.4. By End Users
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Stem Cell Therapy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Source of Stem Cells
7.3.1.2.3. By Application
7.3.1.2.4. By End Users
7.3.2. Germany Stem Cell Therapy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Source of Stem Cells
7.3.2.2.3. By Application
7.3.2.2.4. By End Users
7.3.3. United Kingdom Stem Cell Therapy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Source of Stem Cells
7.3.3.2.3. By Application
7.3.3.2.4. By End Users
7.3.4. Italy Stem Cell Therapy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Source of Stem Cells
7.3.4.2.3. By Application
7.3.4.2.4. By End Users
7.3.5. Spain Stem Cell Therapy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Source of Stem Cells
7.3.5.2.3. By Application
7.3.5.2.4. By End Users

8. North America Stem Cell Therapy Market Outlook

8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Source of Stem Cells
8.2.3. By Application
8.2.4. By End Users
8.2.5. By Country
8.3. North America: Country Analysis
8.3.1. United States Stem Cell Therapy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Source of Stem Cells
8.3.1.2.3. By Application
8.3.1.2.4. By End Users
8.3.2. Mexico Stem Cell Therapy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Source of Stem Cells
8.3.2.2.3. By Application
8.3.2.2.4. By End Users
8.3.3. Canada Stem Cell Therapy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Source of Stem Cells
8.3.3.2.3. By Application
8.3.3.2.4. By End Users

9. South America Stem Cell Therapy Market Outlook

9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Source of Stem Cells
9.2.3. By Application
9.2.4. By End Users
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Stem Cell Therapy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Source of Stem Cells
9.3.1.2.3. By Application
9.3.1.2.4. By End Users
9.3.2. Argentina Stem Cell Therapy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Source of Stem Cells
9.3.2.2.3. By Application
9.3.2.2.4. By End Users
9.3.3. Colombia Stem Cell Therapy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Source of Stem Cells
9.3.3.2.3. By Application
9.3.3.2.4. By End Users

10. Middle East and Africa Stem Cell Therapy Market Outlook

10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Source of Stem Cells
10.2.3. By Application
10.2.4. By End Users
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Stem Cell Therapy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Source of Stem Cells
10.3.1.2.3. By Application
10.3.1.2.4. By End Users
10.3.2. Saudi Arabia Stem Cell Therapy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Source of Stem Cells
10.3.2.2.3. By Application
10.3.2.2.4. By End Users
10.3.3. UAE Stem Cell Therapy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Source of Stem Cells
10.3.3.2.3. By Application
10.3.3.2.4. By End Users

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

13.1. Osiris Therapeutics, Inc.
13.2. MEDIPOST Co., Ltd.
13.3. Anterogen Co., Ltd.
13.4. Pharmicell Co., Ltd.
13.5. Holostem Terapie Avanzate S.r.l.
13.6. JCR Pharmaceuticals Co., Ltd.
13.7. NuVasive, Inc.
13.8. RTI Surgical, Inc.
13.9. AlloSource
13.10. Thermo Fisher Scientific

14. Strategic Recommendations15. About Us & Disclaimer